Key Market Indicators
Chilean antirheumatic medicine sales are projected to drop to $62 million by 2026. In 2021, the country ranked 11th worldwide, with Australia overtaking it to reach $67 million. Germany, Spain, and Canada were the second, third, and fourth biggest markets respectively. Since 2005, the Chilean market has declined an average of 1.1% each year, amounting to a total decrease of 5.7%.